Search Results - "Grunberger, J."

Refine Results
  1. 1

    Pupillary response to percutaneous auricular vagus nerve stimulation in alcohol withdrawal syndrome: A pilot trial by Treiber, M.C., Grünberger, J., Vyssoki, B., Szeles, J.C., Kaniusas, E., Kampusch, S., Stöhr, H., Walter, H., Lesch, O.M., König, D., Kraus, C.

    Published in Alcohol (Fayetteville, N.Y.) (01-02-2024)
    “…Autonomic symptoms in alcohol withdrawal syndrome (AWS) are associated with a sympathetic-driven imbalance of the autonomic nervous system. To restore…”
    Get full text
    Journal Article
  2. 2

    Nicergoline in senile dementia of Alzheimer type and multi-infarct dementia: a double-blind, placebo-controlled, clinical and EEG/ERP mapping study by Saletu, B, Paulus, E, Linzmayer, L, Anderer, P, Semlitsch, H V, Grünberger, J, Wicke, L, Neuhold, A, Podreka, I

    Published in Psychopharmacology (01-02-1995)
    “…In a double-blind, placebo-controlled study on the therapeutic efficacy and central effects of nicergoline, an ergot alkaloid with metabolic, antithrombotic…”
    Get full text
    Journal Article
  3. 3

    Drug profiling by computed electroencephalography and brain maps, with special consideration of sertraline and its psychometric effects by Saletu, B, Grünberger, J

    Published in The journal of clinical psychiatry (01-08-1988)
    “…The five main psychopharmacological drug groups are reviewed in respect of their effects on the pharmaco-electroencephalogram (pharmaco-EEG), with special…”
    Get full text
    Journal Article
  4. 4

    On the cerebro‐protective effects of caroverine, a calcium‐channel blocker and antiglutamatergic drug: double‐blind, placebo‐controlled, EEG mapping and psychometric studies under hypoxia by SALETU, B., GRÜNBERGER, J., ANDERER, P., LINZMAYER, L., KÖNIG, P.

    Published in British journal of clinical pharmacology (01-02-1996)
    “…1 In a double‐blind, placebo‐controlled study, the acute antihypoxidotic properties of the calcium‐channel blocking and antiglutamatergic caroverine were…”
    Get full text
    Journal Article
  5. 5

    Memory dysfunction and vigilance: neurophysiological and psychopharmacological aspects by Saletu, B, Grünberger, J

    Published in Annals of the New York Academy of Sciences (01-01-1985)
    “…Human brain function as measured by the computer-assisted spectral analyzed electroencephalogram (EEG) shows significant alterations in normal and pathological…”
    Get more information
    Journal Article
  6. 6

    Comparison between observer assessment and self rating of withdrawal distress during opiate detoxification by Loimer, N, Linzmayer, L, Grünberger, J

    Published in Drug and alcohol dependence (01-10-1991)
    “…The Subjective Opiate Withdrawal Questionnaire (SOWQ) and the Objective Opiate Withdrawal Scale (OOWS) were administered to detect withdrawal distress during a…”
    Get more information
    Journal Article
  7. 7

    Classification and determination of cerebral bioavailability of fluoxetine: pharmacokinetic, pharmaco-EEG, and psychometric analyses by Saletu, B, Grünberger, J

    Published in The journal of clinical psychiatry (01-01-1985)
    “…In a double-blind placebo-controlled cross-over study, the pharmacokinetic, encephalotropic, and psychotropic properties of fluoxetine were investigated in 8…”
    Get full text
    Journal Article
  8. 8

    On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: double-blind placebo-controlled quantitative EEG and psychometric studies by Saletu, B, Grünberger, J, Anderer, R

    “…Utilizing quantitative EEG and psychometric methods we investigated in two subsequent double-blind, placebo-controlled trials the following questions: 1) Does…”
    Get more information
    Journal Article
  9. 9

    Pupillary dilatation test and Fourier analysis of pupillary oscillations in patients with multiple sclerosis by Grünberger, J, Linzmayer, L, Majda, E M, Reitner, A, Walter, H

    “…Recently we investigated 29 patients aged between 31 and 60 years with multiple sclerosis by means of two new techniques. The first technique was based on…”
    Get full text
    Journal Article
  10. 10

    Pharmaco‐EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine by Saletu, B, Grunberger, J, Rajna, P

    “…1 Antidepressant drugs produce significant changes in human brain function as reflected in the quantitatively analysed EEG. Two main types of pharmaco‐EEG…”
    Get full text
    Journal Article
  11. 11

    Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry by Saletu, B, Grünberger, J, Linzmayer, L, Anderer, P

    Published in Pharmacopsychiatry (01-02-1987)
    “…In a double-blind, placebo-controlled study the encephalotropic and psychotropic properties of zotepine - a new tricyclic dibenzothiepine with…”
    Get more information
    Journal Article
  12. 12

    Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry by Saletu, B, Grünberger, J, Linzmayer, L

    “…In a double-blind, placebo-controlled study the encephalotropic and psychotropic properties of gabapentin - a new gaba-analogue with anticonvulsant and…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Dose-response studies with co-dergocrine mesylate under hypoxia utilizing EEG mapping and psychometry by SALETU, B, GRÜNBERGER, J, LINZMAYER, L, ANDERER, P

    Published in Psychopharmacologia (01-10-1992)
    “…In a double-blind, placebo-controlled trial, human brain function and mental performance were studied under two different degrees of hypoxia after…”
    Get full text
    Journal Article
  15. 15

    On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies by Saletu, B, Grünberger, J, Linzmayer, L

    “…In a double-blind placebo-controlled study, the encephalotropic and psychotropic properties of a new partial benzodiazepine agonist Ro 16-6028 were…”
    Get more information
    Journal Article
  16. 16

    Quantitative pharmaco‐EEG and performance after administration of brotizolam to healthy volunteers by Saletu, B, Grunberger, J, Linzmayer, L

    Published in British journal of clinical pharmacology (01-01-1983)
    “…The activity of brotizolam (0.1, 0.3 and 0.5 mg) was studied in normal subjects using quantitative pharmaco‐EEG, psychometric and clinical evaluation. Power…”
    Get full text
    Journal Article
  17. 17

    Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations by Saletu, B, Grünberger, J, Linzmayer, L

    Published in Archives of gerontology and geriatrics (01-10-1986)
    “…In a double-blind, placebo-controlled study the encephalotropic and psychotropic properties of acutely and chronically administered milacemide--a new…”
    Get more information
    Journal Article
  18. 18

    Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping by Saletu, B, Anderer, P, Kinsperger, K, Grünberger, J, Sieghart, W

    Published in International clinical psychopharmacology (01-10-1988)
    “…In a double-blind, placebo-controlled study the pharmacokinetic and pharmacodynamic properties of a standard solution of diazepam (DZ) (ValiumR) were compared…”
    Get more information
    Journal Article
  19. 19

    Double-blind, placebo-controlled, clinical, psychometric and neurophysiological investigations with oxiracetam in the organic brain syndrome of late life by Saletu, B, Linzmayer, L, Grünberger, J, Pietschmann, H

    Published in Neuropsychobiology (01-01-1985)
    “…The therapeutic efficacy and safety of oxiracetam (ISF 2522), a new nootropic cyclic GABA derivative, were investigated in a double-blind, placebo-controlled…”
    Get more information
    Journal Article
  20. 20

    Pharmaco-EEG and psychometric studies with a novel selective benzodiazepine agonist/antagonist Ro 23-0364 by Saletu, B, Grünberger, J, Cepko, H

    “…In a double-blind, placebo-controlled study, the encephalotropic and psychotropic properties of Ro 23-0364, a novel imidazobenzodiazepine with mixed…”
    Get more information
    Journal Article